Consideration for License. 4.1 In partial consideration for the rights granted hereunder, NOBLE agrees to prepare and file, or have prepared and filed, any and all applications in the name of UGARF for plant variety rights for the Licensed Variety in the United States and, at NOBLE’s discretion, in any other jurisdiction.
4.1.1 UGARF shall have a right to review any such filing made under this paragraph prior to its submission and be informed of all actions relating to such filings.
4.1.2 NOBLE shall be responsible for any and all fees and expenses incurred in filing, examining, certifying and maintaining any such plant variety rights.
4.1.3 If NOBLE intends to abandon any plant variety rights, pending or otherwise in any jurisdiction, NOBLE shall first give sufficient written notice to UGARF to permit UGARF the opportunity to assume such filing, examination and/or maintenance without prejudice.
4.1.4 Any application for plant variety rights shall reflect the complete name of the Licensed Variety. In consultation with UGARF, a preferred name for the Licensed Variety will be determined under which the seed will be marketed and sold. NOBLE shall be responsible for any and all fees and expenses in obtaining any trademarks or other registrations to secure or reserve such preferred name. NOBLE shall be responsible for the registration or reservation of such preferred name, wherein NOBLE and/or the primary marketer of the Licensed Variety shall be the owner(s) of the same.
4.2 In partial consideration for the rights granted hereunder, NOBLE agrees to pay to UGARF [***] of any and all remuneration it receives from its Sublicensees, excluding royalties based on the Net Selling Price.
4.3 In partial consideration for the rights granted hereunder, NOBLE agrees to pay to UGARF for any sales made by NOBLE, any Affiliated Company, and any Sublicensees for seed of the LICENSED VARIETY, a royalty of:
(a) [***] of the Net Selling Price for the naked seed weight (exclusive of any coating materials that may be applied) of all Commercial Seed of the Licensed Variety sold in the United States in that calendar year up to and including two million (2,000,000) lbs;
(b) [***] of the Net Selling Price for the naked seed weight (exclusive of any coating materials that may be applied) of all Commercial Seed of the Licensed Variety sold in the United States in that calendar year in excess of two million (2,000,000) lbs and up to three million (3,000,000) lbs;
(c) [***] of the NET SELLING PRICE for the naked se...
Consideration for License. In consideration for the license granted to Licensee hereunder, Licensee shall pay to Merck a non-refundable, non-creditable payment of [***] U.S. dollars ($[***]), which shall be due within [***] days of the Effective Date. *** CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.
Consideration for License. For the promises received, Licensee shall pay to Exhaustless a fee of $250,000 at the time of signing of this Agreement. For the promises and consideration given, Exhaustless grants to Licensee the license to the Aviation 2.0 Operating Standard.
Consideration for License. In consideration for the licenses granted to CUBIST under Section 2, CUBIST shall make a cash payment to XTL of USD $1,000,000 within three (3) business days after the Effective Date of this Agreement.
Consideration for License. In consideration for the license granted hereunder, Licensee shall pay to Merck a non-refundable, non-creditable, upfront payment of two hundred thousand U.S. dollars ($200,000.00), which shall be due within thirty (30) days of the Effective Date of this Agreement.
Consideration for License. In consideration for the grant of the License by the Licensor to the Licensee pursuant to Section 1 of this Agreement, the Licensee hereby agrees to pay to the Licensor one dollar and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the Licensor.
Consideration for License. In consideration for the license granted hereunder, Licensee shall pay to Lilly a non-refundable, non-creditable, upfront payment of one million U.S. dollars ($1,000,000.00), seven hundred fifty thousand U.S. dollars ($750,000.00) of which shall be due within thirty (30) days of the Effective Date of this Agreement, and the remaining balance of two hundred fifty thousand U.S. dollars ($250,000.00) payable within thirty (30) days of completion of the final study report for the 9-month chronic toxicology study to be conducted by Licensee in non-human primates.
Consideration for License. In consideration for the licenses granted pursuant to Article 3 and the research obligations set forth herein, upon the terms and conditions contained herein, Merck shall pay to Vertex a one-time payment of twenty million dollars (US $20,000,000) within five (5) business days of the Effective Date.
Consideration for License. In consideration for the grant of the License by the Licensor to the Licensee pursuant to Section 1 of this Agreement, the Licensee hereby issues to the Licensor 4,605,337 shares of common stock in the Licensee. Accordingly, Licensor will have all of the rights, authority, and duties set forth for him as a shareholder of the Licensee.
Consideration for License. Upon the execution of the Agreement, LICENSEE to LICENSOR. Said represent the consideration paid by LICENSEE to LICENSOR for the rights granted under this Agreement
